por
Fasano, Morena,
Pirozzi, Mario,
Famiglietti, Vincenzo,
Facchini, Sergio,
Caterino, Marianna,
Caroprese, Mara,
Barillaro, Angela,
Di Giovanni, Ilaria,
Auriemma, Annunziata,
Ileana Sara Fattoruso, Silvia,
Somma, Teresa,
Solari, Domenico,
Bocchetti, Marco,
Conson, Manuel,
Pacelli, Roberto,
Ciardiello, Fortunato,
Addeo, Raffaele
Publicado 2023
“…In the present study, a real-life retrospective investigation on the role of regorafenib in patients with recurrent glioblastoma (>60 years old) from two main Oncological Units in South Italy (Azienda Ospedaliera Universitaria Luigi Vanvitelli, Naples, Italy and Ospedale Civile San Giovanni di Dio,
Frattamaggiore, Naples, Italy), was performed. The primary endpoint was overall survival (OS), whereas progression-free survival (PFS), objective response rate and disease control were secondary endpoints. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto
